This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Richard Kevin Andrews net worth and biography

Richard Andrews Biography and Net Worth

CFO of Battalion Oil

Kevin Andrews serves as Executive Vice President, CFO and Treasurer. Mr. Andrews joined Battalion Oil in August 2020. He has over 30 years of financial management experience including investment banking, industry and public accounting roles.

He spent the previous 19 years as a Managing Director and Head of Energy Investment Banking at Imperial Capital, Wunderlich Securities, Pritchard Capital Partners and Morgan Keegan. Mr. Andrews led and participated in hundreds of public and private transactions in the debt and equity markets and has had extensive merger and acquisition experience in the oil and gas industry.

Prior to his career in investment banking, Mr. Andrews was CFO of Denali Incorporated and Financial Manager at both Moorco International and Envirotech, a Baker Hughes subsidiary.

Mr. Andrews began his career at Coopers & Lybrand in 1987 after receiving an MBA and a Bachelor of Business Administration degree in Accounting from The University of Tulsa.

What is Richard Kevin Andrews' net worth?: The estimated net worth of Richard Kevin Andrews is at least $38,823.84 as of June 10th, 2022. Mr. Andrews owns 7,524 shares of Battalion Oil stock worth more than $38,824 as of April 25th. This net worth estimate does not reflect any other assets that Mr. Andrews may own. Learn More about Richard Kevin Andrews' net worth.
How do I contact Richard Kevin Andrews?: The corporate mailing address for Mr. Andrews and other Battalion Oil executives is 1000 LOUISIANA STREET SUITE 6600, HOUSTON TX, 77002. Battalion Oil can also be reached via phone at 832-538-0300 and via email at [email protected]. Learn More on Richard Kevin Andrews' contact information.
Has Richard Kevin Andrews been buying or selling shares of Battalion Oil?: Richard Kevin Andrews has not been actively trading shares of Battalion Oil during the last quarter. Most recently, on Friday, June 10th, Richard Kevin Andrews bought 300 shares of Battalion Oil stock. The stock was acquired at an average cost of $14.08 per share, with a total value of $4,224.00. Following the completion of the transaction, the chief financial officer now directly owns 7,524 shares of the company's stock, valued at $105,937.92. Learn More on Richard Kevin Andrews' trading history.
Who are Battalion Oil's active insiders?: Battalion Oil's insider roster includes Richard Andrews (CFO), Grant Evans (VP), Scott Germann (Director), Leah Kasparek (SVP), Richard Little (CEO), William Rogers (Director), and Daniel Rohling (COO). Learn More on Battalion Oil's active insiders.

Richard Kevin Andrews Insider Trading History at Battalion Oil

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/10/2022	Buy	300	$14.08	$4,224.00	7,524
6/1/2022	Buy	300	$15.04	$4,512.00	7,224
12/7/2021	Buy	150	$10.69	$1,603.50
9/10/2021	Buy	1,550	$7.92	$12,276.00	6,574

Richard Kevin Andrews Buying and Selling Activity at Battalion Oil

Battalion Oil Company Overview

Battalion Oil Corporation, an independent energy company, engages in the acquisition, production, exploration, and development of onshore oil and natural gas assets in the United States. It holds interests in the Delaware Basin located in the counties of Pecos, Ward, Reeves, and Winkler, Texas. It serves independent marketers, and oil and natural gas and gas pipeline companies. The company was formerly known as Halcón Resources Corporation and changed its name to Battalion Oil Corporation in January 2020. Battalion Oil Corporation was founded in 1987 and is headquartered in Houston, Texas.

Today's Range

Now: $5.16

$5.11

$5.38

50 Day Range

MA: $5.81

$5.11

$7.08

2 Week Range

Now: $5.16

$4.51

$9.69

Volume

2,127 shs

Average Volume

109,304 shs

Market Capitalization

$84.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad